ARTICLE | Clinical News
Zometa zoledronic acid regulatory update
December 4, 2000 8:00 AM UTC
NOVN received marketing approval in Switzerland for Zometa, an intravenous bisphosphonate to treat hypercalcemia associated with cancer. The product has received an approvable letter from the FDA and ...